A Phase 1/2 Study Evaluating Multiple Nivolumab Combination Therapy in Participants With Stage IV Non-small Cell Lung Cancer That Has Spread or Has Reoccurred After Failure of Chemotherapy and Immunotherapy

2019 ◽  
Author(s):  
Keyword(s):  
Lung Cancer ◽  
Combination Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Stage Iv ◽  
Small Cell ◽  
Small Cell Lung

Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer

Lung Cancer ◽  
2020 ◽  
Vol 142 ◽  
pp. 63-69
Author(s):  
Benjamin Besse ◽  
Pilar Garrido ◽  
Alexis B. Cortot ◽  
Melissa Johnson ◽  
Haruyasu Murakami ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Combination Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

scholarly journals Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)

2017 ◽  
Vol 28 ◽  
pp. v466 ◽  
Author(s):  
B. Besse ◽  
P. Garrido Lopez ◽  
J. Puente ◽  
A. Cortot ◽  
M.E. Olmedo Garcia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Combination Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

scholarly journals MA09.11 Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

2017 ◽  
Vol 12 (1) ◽  
pp. S397 ◽  
Author(s):  
Benjamin Besse ◽  
Pilar Garrido ◽  
Javier Puente ◽  
Alexis Cortot ◽  
Maria Eugenia Olmedo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Combination Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document